Helen Burt
#156,427
Most Influential Person Now
British-Canadian pharmaceutical scientist
Helen Burt's AcademicInfluence.com Rankings
Helen Burtmedical Degrees
Medical
#3631
World Rank
#4116
Historical Rank
Pharmacology
#468
World Rank
#525
Historical Rank
Helen Burtphilosophy Degrees
Philosophy
#10778
World Rank
#14792
Historical Rank
Logic
#7627
World Rank
#9450
Historical Rank
Download Badge
Medical Chemistry Philosophy
Why Is Helen Burt Influential?
(Suggest an Edit or Addition)According to Wikipedia, Helen M. Burt is a British-Canadian pharmaceutical scientist who is the Angiotech Professor of Drug Delivery at the University of British Columbia. She serves as Associate Vice President of Research and Innovation at UBC. Her research considers novel therapeutics based on nanotechnology, including drug delivery systems for the treatment of bladder cancer and coronary artery disease.
Helen Burt's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- A review of the formation and classification of amphiphilic block copolymer nanoparticulate structures: micelles, nanospheres, nanocapsules and polymersomes. (2007) (985)
- Development of amphiphilic diblock copolymers as micellar carriers of taxol (1996) (361)
- The use of nanocrystalline cellulose for the binding and controlled release of drugs (2011) (299)
- Polyether-polyester diblock copolymers for the preparation of paclitaxel loaded polymeric micelle formulations. (2002) (258)
- Development of copolymers of poly(d,l-lactide) and methoxypolyethylene glycol as micellar carriers of paclitaxel (1999) (235)
- Solubilization of hydrophobic drugs by methoxy poly(ethylene glycol)-block-polycaprolactone diblock copolymer micelles: theoretical and experimental data and correlations. (2008) (233)
- Solid-state characterization of paclitaxel. (1997) (205)
- The antioxidants curcumin and quercetin inhibit inflammatory processes associated with arthritis (2006) (153)
- A review of nanocellulose as a novel vehicle for drug delivery (2014) (140)
- Determination of surfactant critical micelle concentration by a novel fluorescence depolarization technique. (1996) (137)
- Drug-eluting stents: a multidisciplinary success story. (2006) (134)
- Solubility and stability of taxol: effects of buffers and cyclodextrins (1996) (131)
- Paclitaxel loaded poly(L-lactic acid) microspheres: properties of microspheres made with low molecular weight polymers. (2001) (120)
- Polymeric drug delivery of platinum-based anticancer agents. (2009) (114)
- An investigation of the antitumour activity and biodistribution of polymeric micellar paclitaxel (1997) (109)
- Anti-tumor efficacy and biodistribution of intravenous polymeric micellar paclitaxel (1997) (109)
- Human plasma distribution of free paclitaxel and paclitaxel associated with diblock copolymers. (1997) (104)
- On-demand controlled release of docetaxel from a battery-less MEMS drug delivery device. (2011) (103)
- Fusidic acid and rifampicin co-loaded PLGA nanofibers for the prevention of orthopedic implant associated infections. (2013) (102)
- Controlled delivery of taxol from microspheres composed of a blend of ethylene-vinyl acetate copolymer and poly (d,l-lactic acid). (1995) (94)
- A magnetically controlled MEMS device for drug delivery: design, fabrication, and testing. (2011) (94)
- Enhanced cellular accumulation of a P-glycoprotein substrate, rhodamine-123, by Caco-2 cells using low molecular weight methoxypolyethylene glycol-block-polycaprolactone diblock copolymers. (2002) (92)
- Unimolecular micelles based on hydrophobically derivatized hyperbranched polyglycerols: ligand binding properties. (2008) (92)
- In vitro human plasma distribution of nanoparticulate paclitaxel is dependent on the physicochemical properties of poly(ethylene glycol)-block-poly(caprolactone) nanoparticles. (2009) (89)
- A PLGA membrane controlling cell behaviour for promoting tissue regeneration. (2005) (88)
- Methotrexate loaded poly(L-lactic acid) microspheres for intra-articular delivery of methotrexate to the joint. (2004) (88)
- Paclitaxel loaded poly(L-lactic acid) microspheres for the prevention of intraperitoneal carcinomatosis after a surgical repair and tumor cell spill. (2000) (82)
- The inhibition of collagenase induced degradation of collagen by the galloyl-containing polyphenols tannic acid, epigallocatechin gallate and epicatechin gallate (2010) (81)
- In vitro chelating, cytotoxicity, and blood compatibility of degradable poly(ethylene glycol)-based macromolecular iron chelators. (2009) (80)
- Intra-articular treatment of arthritis with microsphere formulations of paclitaxel: biocompatibility and efficacy determinations in rabbits (2004) (78)
- Crystal defects and dissolution (1981) (77)
- Drug-eluting stents: factors governing local pharmacokinetics. (2006) (77)
- Enhanced gap filling and osteoconduction associated with alendronate-calcium phosphate-coated porous tantalum. (2008) (75)
- Synthesis and characterization of carboxylic acid conjugated, hydrophobically derivatized, hyperbranched polyglycerols as nanoparticulate drug carriers for cisplatin. (2011) (73)
- Development of a Polymeric Surgical Paste Formulation for Taxol (1996) (73)
- Taxol encapsulation in poly(ɛ-caprolactone) microspheres (2004) (70)
- Paclitaxel incorporated in hydrophobically derivatized hyperbranched polyglycerols for intravesical bladder cancer therapy (2009) (69)
- Paclitaxel-Loaded Crosslinked Hyaluronic Acid Films for the Prevention of Postsurgical Adhesions (2002) (65)
- Paclitaxel loaded poly(L-lactic acid) (PLLA) microspheres. II. The effect of processing parameters on microsphere morphology and drug release kinetics. (2004) (65)
- Characterization of perivascular poly(lactic-co-glycolic acid) films containing paclitaxel. (2004) (64)
- Synthesis and micellar characterization of short block length methoxy poly(ethylene glycol)-block-poly(caprolactone) diblock copolymers. (2004) (63)
- The suppression of human prostate tumor growth in mice by the intratumoral injection of a slow-release polymeric paste formulation of paclitaxel. (2000) (62)
- Complete inhibition of intimal hyperplasia by perivascular delivery of paclitaxel in balloon-injured rat carotid arteries. (2001) (59)
- Hyperbranched polymers for controlled release of cisplatin. (2008) (56)
- Release of taxol from poly(ϵ-caprolactone) pastes: effect of water-soluble additives (1997) (54)
- Growth of monosodium urate monohydrate crystals: effect of cartilage and synovial fluid components on in vitro growth rates. (1986) (54)
- Copolymer micelles and nanospheres with different in vitro stability demonstrate similar paclitaxel pharmacokinetics. (2012) (53)
- Neutrophil activation by plasma opsonized polymeric microspheres: inhibitory effect of pluronic F127. (2000) (53)
- Fabrication of robust hydrogel coatings on polydimethylsiloxane substrates using micropillar anchor structures with chemical surface modification. (2014) (52)
- In vivo Evaluation of Mucoadhesive Nanoparticulate Docetaxel for Intravesical Treatment of Non–Muscle-Invasive Bladder Cancer (2011) (51)
- Development of biodegradable polymeric paste formulations for taxol: An in vitro and in vivo study (1996) (50)
- Evidence for Modulation of P-glycoprotein-Mediated Efflux by Methoxypolyethylene Glycol-block-Polycaprolactone Amphiphilic Diblock Copolymers (2004) (49)
- The application of layered double hydroxide clay (LDH)-poly(lactide-co-glycolic acid) (PLGA) film composites for the controlled release of antibiotics (2012) (48)
- Paclitaxel-loaded poly(L-lactic acid) microspheres 3: blending low and high molecular weight polymers to control morphology and drug release. (2004) (48)
- P-glycoprotein efflux inhibition by amphiphilic diblock copolymers: relationship between copolymer concentration and substrate hydrophobicity. (2008) (48)
- Intra-articular drug delivery systems: overcoming the shortcomings of joint disease therapy (2009) (47)
- Intravesically administered antisense oligonucleotides targeting heat‐shock protein‐27 inhibit the growth of non‐muscle‐invasive bladder cancer (2008) (47)
- Drug intercalation in layered double hydroxide clay: application in the development of a nanocomposite film for guided tissue regeneration. (2011) (45)
- An in vitro study of plasticized poly(lactic-co-glycolic acid) films as possible guided tissue regeneration membranes: material properties and drug release kinetics. (2010) (44)
- Topoisomerase inhibitors as anti-arthritic agents (2008) (44)
- The characterization of paclitaxel-loaded microspheres manufactured from blends of poly(lactic-co-glycolic acid) (PLGA) and low molecular weight diblock copolymers. (2007) (42)
- Pharmacokinetic study of methotrexate following intra-articular injection of methotrexate loaded poly(L-lactic acid) microspheres in rabbits. (2005) (42)
- Calcium pyrophosphate and monosodium urate crystal interactions with neutrophils: effect of crystal size and lipoprotein binding to crystals. (1989) (42)
- The Gurnham equation in characterizing the compressibility of pharmaceutical materials. (2006) (41)
- Effect of habit modification on dissolution rate (1980) (40)
- Paclitaxel and cisplatin as intravesical agents against non‐muscle‐invasive bladder cancer (2008) (37)
- A polymer-based drug delivery system for the antineoplastic agent bis(maltolato)oxovanadium in mice. (1997) (37)
- Methoxypolyethylene glycol-block-polycaprolactone diblock copolymers reduce P-glycoprotein efflux in the absence of a membrane fluidization effect while stimulating P-glycoprotein ATPase activity. (2007) (36)
- High-performance liquid chromatographic analysis of oxytetracycline in chinook salmon following administration of medicated feed. (1991) (36)
- Reversal of multidrug resistance by methoxypolyethylene glycol-block-polycaprolactone diblock copolymers through the inhibition of P-glycoprotein function. (2009) (36)
- The characterization of novel polymeric paste formulations for intratumoral delivery. (2004) (36)
- The inhibition of angiogenesis by antisense oligonucleotides to clusterin (2005) (34)
- Camptothecin-loaded films for the prevention of postsurgical adhesions (2004) (34)
- Efficacy of an intratumoral controlled release formulation of clusterin antisense oligonucleotide complexed with chitosan containing paclitaxel or docetaxel in prostate cancer xenograft models (2005) (34)
- Taxol encapsulation in poly(epsilon-caprolactone) microspheres. (1995) (33)
- Tissue uptake of docetaxel loaded hydrophobically derivatized hyperbranched polyglycerols and their effects on the morphology of the bladder urothelium. (2012) (33)
- Inhibition of TNF-α-Induced Neutrophil Apoptosis by Crystals of Calcium Pyrophosphate Dihydrate Is Mediated by the Extracellular Signal-Regulated Kinase and Phosphatidylinositol 3-Kinase/Akt Pathways Up-Stream of Caspase 31 (2000) (32)
- Calcium pyrophosphate dihydrate crystals activate MAP kinase in human neutrophils: inhibition of MAP kinase, oxidase activation and degranulation responses of neutrophils by taxol (1997) (31)
- Phase separation behavior of fusidic acid and rifampicin in PLGA microspheres. (2012) (30)
- Development and in vitro characterization of paclitaxel and docetaxel loaded into hydrophobically derivatized hyperbranched polyglycerols. (2011) (29)
- In vitro and in vivo evaluation of intravesical docetaxel loaded hydrophobically derivatized hyperbranched polyglycerols in an orthotopic model of bladder cancer. (2011) (29)
- The inhibition of spontaneous and tumor necrosis factor-alpha induced neutrophil apoptosis by crystals of calcium pyrophosphate dihydrate and monosodium urate monohydrate. (2000) (28)
- Oxytetracycline degradation in thermally processed farmed salmon (1992) (28)
- The preparation and characterization of anti-VEGFR2 conjugated, paclitaxel-loaded PLLA or PLGA microspheres for the systemic targeting of human prostate tumors (2008) (28)
- Amphiphilic dextran-graft-poly(ε-caprolactone) films for the controlled release of paclitaxel (2004) (27)
- Synthesis and characterization of amphiphilic hydroxypropylcellulose‐graft‐poly(ε‐caprolactone) (2003) (27)
- The involvement of phosphatidylinositol 3-kinase in crystal induced human neutrophil activation. (1997) (27)
- Increased accumulation and retention of micellar paclitaxel in drug-sensitive and P-glycoprotein-expressing cell lines following ultrasound exposure. (2012) (27)
- Use of fibrin sealants for the localized, controlled release of cefazolin. (2006) (26)
- Composite Hydrogel Formulations of Stratifin to Control MMP-1 Expression in Dermal Fibroblasts (2009) (26)
- Crystal-induced protein tyrosine phosphorylation in neutrophils and the effect of a tyrosine kinase inhibitor on neutrophil responses. (1993) (24)
- Drug Uptake Enhancement Using Sonodynamic Effects at 4 MHz—A Potential Application for Micro-Ultrasonic-Transducers (2007) (24)
- Activation of S6 kinase in human neutrophils by calcium pyrophosphate dihydrate crystals: protein kinase C-dependent and phosphatidylinositol-3-kinase-independent pathways. (1998) (24)
- The use of bone cement for the localized, controlled release of the antibiotics vancomycin, linezolid, or fusidic acid: effect of additives on drug release rates and mechanical strength (2011) (23)
- The encapsulation of ribozymes in biodegradable polymeric matrices. (2002) (23)
- Selective Recognition of Rituximab-Functionalized Gold Nanoparticles by Lymphoma Cells Studied with 3D Imaging (2009) (22)
- High-performance liquid chromatographic analysis of Romet-30 in salmon following administration of medicated feed. (1990) (22)
- Controlled Release of Alendronate from Polymeric Films (2009) (22)
- Increased accumulation of paclitaxel and doxorubicin in proliferating capillary cells and prostate cancer cells following ultrasound exposure. (2011) (21)
- Effects of continuous and pulsatile PTH treatments on rat bone marrow stromal cells. (2009) (21)
- The uptake of paclitaxel and docetaxel into ex vivo porcine bladder tissue from polymeric micelle formulations (2011) (21)
- The priming action of tumour necrosis factor‐alpha (TNF‐α) and granulocyte‐macrophage colony‐stimulating factor (GM‐CSF) on neutrophils activated by inflammatory microcrystals (1997) (21)
- The involvement of phospholipase C in crystal induced human neutrophil activation. (2000) (21)
- Clusterin antisense complexed with chitosan for controlled intratumoral delivery. (2008) (20)
- The combined use of paclitaxel-loaded nanoparticles with a low-molecular-weight copolymer inhibitor of P-glycoprotein to overcome drug resistance (2013) (19)
- The development of a novel intraperitoneal tumor-seeding prophylactic. (1997) (19)
- Activation of Human Neutrophils by Calcium Carbonate Polymorphs (1997) (19)
- The use of tissue sealants to deliver antibiotics to an orthopaedic surgical site with a titanium implant (2013) (18)
- Intra-articular treatment of inflammatory arthritis with microsphere formulations of methotrexate: pharmacokinetics and efficacy determination in antigen-induced arthritic rabbits (2009) (18)
- Dissolution anisotropy in nickel sulfate α hexahydrate crystals (1979) (18)
- The antineoplastic ether lipid, s-phosphonate, selectively induces apoptosis in human leukemic cells and exhibits antiangiogenic and apoptotic activity on the chorioallantoic membrane of the chick embryo (1998) (16)
- Mechanism of hemolysis of human erythrocytes exposed to monosodium urate monohydrate crystals. Preliminary characterization of membrane pores. (1996) (15)
- The effect of inhibiting topoisomerase I and II on the antiapoptotic response associated with pro-inflammatory crystals of calcium pyrophosphate dihydrate in human neutrophils (2003) (14)
- Enhancement of crystal induced neutrophil responses by opsonisation of calcium pyrophosphate dihydrate crystals. (1993) (14)
- Intra-articular drug delivery systems: Overcoming the shortcomings of joint disease therapy. (2009) (14)
- Drug-eluting stents: an innovative multidisciplinary drug delivery platform. (2006) (13)
- Ion-exchange resins as potential phosphate-binding agents for renal failure patients: effect of the physicochemical properties of resins on phosphate and bile salt binding. (1987) (13)
- Same-single-cell analysis using the microfluidic biochip to reveal drug accumulation enhancement by an amphiphilic diblock copolymer drug formulation (2014) (13)
- The solid-state characterization of fusidic acid. (2012) (13)
- Microspheres as resistive elements in a check valve for low pressure and low flow rate conditions. (2012) (13)
- A Preliminary Report on the Effects of Paclitaxel-Impregnated Stents on Sheep Nasal Mucosa (2004) (13)
- Enhanced taxane uptake into bladder tissues following co‐administration with either mitomycin C, doxorubicin or gemcitabine: association to exfoliation processes (2018) (12)
- Membranolytic effects of crystalline monosodium urate monohydrate. (1983) (12)
- Enzyme‐Modified Hydrogel Coatings with Self‐Cleaning Abilities for Low Fouling PDMS Devices (2015) (12)
- Role of membrane proteins in monosodium urate crystal-membrane interactions. I. Effect of pretreatment of erythrocyte membranes with glutaraldehyde and neuraminidase. (1990) (11)
- High-performance liquid chromatographic determination of sulphadiazine and trimethoprim in Chinook salmon muscle tissue (1993) (11)
- Selective inhibition of protein kinase C, mitogen-activated protein kinase, and neutrophil activation in response to calcium pyrophosphate dihydrate crystals, formyl-methionyl-leucyl-phenylalanine, and phorbol ester by O-(chloroacetyl-carbamoyl) fumagillol (AGM-1470; TNP-470). (1999) (11)
- Calcium pyrophosphate dihydrate crystal associated induction of neutrophil activation and repression of TNF-α-induced apoptosis is mediated by the p38 MAP kinase (2004) (11)
- Characterization and membranolytic effects of triclinic calcium pyrophosphate dihydrate crystals. (1987) (10)
- The Design, Characterization and Antibacterial Activity of Heat and Silver Crosslinked Poly(Vinyl Alcohol) Hydrogel Forming Dressings Containing Silver Nanoparticles (2021) (9)
- Design and Near-Infrared Actuation of a Gold Nanorod–Polymer Microelectromechanical Device for On-Demand Drug Delivery (2018) (9)
- Calcium pyrophosphate dihydrate crystal-induced inhibition of neutrophil apoptosis: involvement of Bcl-2 family members (2009) (9)
- Cytosolic Ca2+ concentration determinations in neutrophils stimulated by monosodium urate and calcium pyrophosphate crystals: effect of protein adsorption. (1994) (8)
- The use of ultrasound to increase the uptake and cytotoxicity of dual taxane and P-glycoprotein inhibitor loaded, solid core nanoparticles in drug resistant cells. (2020) (8)
- Lactide and Glycolide Polymers (2011) (8)
- Development of an assay for penicillin G in chinook salmon muscle tissue (1992) (7)
- The dehydration of nickel sulfate (1980) (7)
- Delivery of an anti-cancer drug from a magnetically controlled MEMS device show cytotoxicity in PC3 and HUVEC cells (2011) (7)
- Mixed molecular weight copolymer nanoparticles for the treatment of drug-resistant tumors: formulation development and cytotoxicity. (2014) (7)
- Crystal-induced inflammation: studies of the mechanism of crystal-membrane interactions. (1991) (6)
- The interaction of monoclinic calcium pyrophosphate dihydrate crystals with neutrophils (2005) (6)
- Controlled delivery of antiangiogenic drug to human eye tissue using a MEMS device (2013) (6)
- Crystallization of monosodium urate monohydrate (1989) (6)
- Role of membrane proteins in monosodium urate crystal-membrane interactions. II. Effect of pretreatments of erythrocyte membranes with membrane permeable and impermeable protein crosslinking agents. (1990) (6)
- The Combined Use of Gentamicin and Silver Nitrate in Bone Cement for a Synergistic and Extended Antibiotic Action against Gram-Positive and Gram-Negative Bacteria (2021) (6)
- Monosodium urate monohydrate crystal induced changes in membrane fluidity: a fluorescence polarization study. (1988) (6)
- Tissue Permeability Effects Associated with the Use of Mucoadhesive Cationic Nanoformulations of Docetaxel in the Bladder (2016) (5)
- In vitro studies using ion exchange resins as potential phosphate binders for renal failure patients. (1985) (4)
- A spin label study of the membranolytic effects of crystalline monosodium urate monohydrate. (1986) (4)
- Calcium pyrophosphate dihydrate crystal associated induction of neutrophil activation and repression of TNF-alpha-induced apoptosis is mediated by the p38 MAP kinase. (2004) (4)
- Membranolytic effects of monosodium urate monohydrate: influence of grinding. (1986) (4)
- The Development of Solvent Cast Films or Electrospun Nanofiber Membranes Made from Blended Poly Vinyl Alcohol Materials with Different Degrees of Hydrolyzation for Optimal Hydrogel Dissolution and Sustained Release of Anti-Infective Silver Salts (2021) (3)
- Determining the Critical Micelle Concentration of a Novel Lipid‐Lowering Agent, Disodium Ascorbyl Phytostanyl Phosphate (FM‐VP4), Using a Fluorescence Depolarization Procedure (2004) (3)
- EFFECT OF ALENDRONATE-CONTAINING COATINGS ON OSTEOINTEGRATION INTO POROUS TANTALUM IN A CORTICAL BONE MODEL (2012) (3)
- Interaction between oral contraceptives and other drugs. (1980) (3)
- A chronic human carrier of B. aertrycke (Bact. typhi‐murium) treated by cholecystectomy (1944) (3)
- A comparison of the lytic properties of two ether-linked lipids, one with and one without antineoplastic activity. (1994) (3)
- CPPD crystal-induced suppression of neutrophil apoptosis is regulated by the ERK1/2 and PI3-kinase/Akt pathways (2002) (2)
- Amphiphilic dextran-graft-poly(epsilon-caprolactone) films for the controlled release of paclitaxel. (2004) (2)
- Microspheres and drug therapy—pharmacological, immunological and medical aspects: Stanley S. Davis, Lisbeth Illum, J. Gordon McVie, Eric Tomlinson, Editors, New York: Elsevier, 1984, pp. xviii + 448 (1986) (2)
- A case of kaposiform haemangioendothelioma successfully and safely treated with sirolimus (2017) (2)
- 494 IN VIVO EVALUATION OF MUCOADHESIVE NANOPARTICULATE DOCETAXEL AND PACLITAXEL LOADED HYDROPHOBICALLY DERIVATIZED HYPERBRANCHED POLYGLYCEROLS FOR INTRAVESICAL BLADDER CANCER THERAPY (2011) (2)
- Alendronate-Calcium Phosphate-Coated Porous Tantalum Enhanced Gap Filling and Osteoconduction Associated with (2010) (1)
- Polyglycerols hyper-ramifies substitues (2011) (0)
- Anti-angiogenic agents containing taxol and a non-biodegradable carrier and their use (1994) (0)
- Effect of crystal anisotropy and crystal defects on dissolution (1980) (0)
- Polymeric Nanofibers Co-loaded with Fusidic Acid & Rifampicin for the Prevention of Implant Associated Infections (2012) (0)
- th Combined Meeting of the Orthopaedic Research Societies Antibiotic Loaded Tissue Sealant for the Prevention of Postoperative Infection in Orthopedic Procedures (2007) (0)
- 306 MUCOADHESIVE PACLITAXEL FOR INTRAVESICAL BLADDER CANCER THERAPY (2009) (0)
- Tissue Permeability Effects Associated with the Use of Mucoadhesive Cationic Nanoformulations of Docetaxel in the Bladder (2016) (0)
- Anti-angiogenic agents and methods of use thereof (1994) (0)
- Micellar drug administration system for hydrophobic drug substances (2002) (0)
- Manufacturing method of a stent having anti-angiogenic composition (1994) (0)
- MP61-18 A NOVEL FORMULATION OF DOCETAXEL WITH ACTIVITY IN MUSCLE INVASIVE BLADDER CANCER XENOGRAFTS (2016) (0)
- ZETA POTENTIAL AND MEMBRANOLYTIC EFFECTS OF CRYSTALLINE MONOSODIUM URATE MONOHYDRATE (1982) (0)
- Fucanos use in the treatment of adhesions, arthritis and psoriasis. (2002) (0)
- Anti-angiogenic agents and methods for their use (1994) (0)
- anti-angiogenic compositions containing taxol and a nonbiodegradable and vehicle use. (1994) (0)
- 33. IN VITRO ACTIVITY OF FUSIDIC ACID AND VANCOMYCIN IN PMMA BONE CEMENT FOR THE TREATMENT OF METHICILLIN-RESISTANT STAPHLYOCOCCUS AUREUS (2011) (0)
- Cancer Therapy : Preclinical In vivo Evaluation of Mucoadhesive Nanoparticulate Docetaxel for Intravesical Treatment of Non – Muscle-Invasive Bladder Cancer (2011) (0)
- antiangiogenic Stents and methods for their preparation. (1994) (0)
- Antiangiogenic Compositions and methods and use. (1994) (0)
- Growthofmonosodium uratemonohydrate crystals: effect ofcartilage andsynovial fluid components on in vitrogrowth rates (1986) (0)
- Using fucans in the treatment of adhäsion, arthritis and psoriasis (2002) (0)
- Determination of surfactant critical micelle (2003) (0)
- The effect of DNA topoisomerase inhibitor-loaded films on postsurgical adhesion formation in the rat (2004) (0)
- Anti-angiogenic compositions and methods of use thereof (1994) (0)
- Micellar delivery systems for drug hirofobicos drugs. (2002) (0)
- Anti-angiogenic compositions comprising taxol and a non-biodegradable carrier and the use thereof (1994) (0)
- Anti-angiogenic stents and methods of making them (1994) (0)
- 661 Enhanced tissue uptake of docetaxel loaded hydrophobically derivatized hyperbranched polyglycerols and their effects on the morphology of the bladder urothelium (2012) (0)
This paper list is powered by the following services:
Other Resources About Helen Burt
What Schools Are Affiliated With Helen Burt?
Helen Burt is affiliated with the following schools:
